Interim Canadian recommendations for the use of a fractional dose of yellow fever vaccine during a vaccine shortage.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A Perspective.Infection and drug resistance · 2023
   Article
2. 2018 in review: five hot topics in tropical medicine.Tropical diseases, travel medicine and vaccines · 2019
   Review
3. Interim Canadian Recommendations for the use of fractional dose of yellow fever vaccine during a vaccine shortage: Now in effect.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2017
   Article
4. Update regarding interim Canadian recommendations for the use of a fractional dose of yellow fever vaccine during a vaccine shortage.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2016
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract